Clarified Precision Medicine
Clarified Precision Medicine offers a scalable, asynchronous Molecular Tumor Board solution that combines a technology platform with a medical group to interpret genomic tumor profiling. Their expert medical team uses AI to deliver a final review of recommended therapies based on NCCN guidelines. The company aims to make precision medicine accessible and actionable for oncologists, patients, and life science partners. They report that their solutions lead to a greater than 50% increase in the clinical recommendation of targeted therapies, a 20X+ ROI for payers through improved outcomes and cost savings, providers changing prescriptions in 30% of cases with time savings up to 1 hour per patient, and an increase in guidelines-based NGS test utilization from 18% to 80% in three months. Patients benefit from receiving the right treatment at the right time, 100% of the time.
Clarified Precision Medicine
Clarified Precision Medicine offers a scalable, asynchronous Molecular Tumor Board solution that combines a technology platform with a medical group to interpret genomic tumor profiling. Their expert medical team uses AI to deliver a final review of recommended therapies based on NCCN guidelines. The company aims to make precision medicine accessible and actionable for oncologists, patients, and life science partners. They report that their solutions lead to a greater than 50% increase in the clinical recommendation of targeted therapies, a 20X+ ROI for payers through improved outcomes and cost savings, providers changing prescriptions in 30% of cases with time savings up to 1 hour per patient, and an increase in guidelines-based NGS test utilization from 18% to 80% in three months. Patients benefit from receiving the right treatment at the right time, 100% of the time.